What we are learning about Alzheimer’s disease genetics Bryan J. Traynor.

Slides:



Advertisements
Similar presentations
¨ Dr Alain Garcia General Secretary of the Rare Diseases National Plan The second National Plan for Rare Diseases in France
Advertisements

Parkinson’s disease (PD) is one of the most common chronic progressive neurodegenerative diseases. PD has a prevalence of 1.2 million people in Europe.
UCL Institute of Ophthalmology Department of Genetics
Quality of CareResearch Programme > Comorbidity: The aetiological / genetic perspective Martina C. Cornel, professor of community genetics & public health.
Question: What do we know about the elusive nature of the pathogenesis of Alzheimer's disease? How can personalized medicine, or the application of genomics.
7.2.d Students know plant and animal cells contain many thousands of different genes and typically have two copies of every gene. The two copies (or alleles)
Aging, Memory and Alzheimer’s Disease Kinga Szigeti, MD, PhD.
Pharmacogenomics: Implications for CNS Drug Development in the 21st Century Challenges for Development & Approval – Patient & Funding Agency Perspective.
Welcome Rebecca Wood Chief Executive. Welcome Alzheimer’s Research UK.
Knowledge Discovery in Biomedicine Limsoon Wong Institute for Infocomm Research.
Chapter 13 Carrier Screening. Introduction Carrier screening involves testing of individuals for heterozygosity for genes that would produce significant.
Alzheimer’s. What is it? Type of dementia Progressive brain disease Effects memory, thinking and behavior problems.
The HCV vaccine: cooperation in the shadow of the pyramids Antonella Folgori.
Genes, which are carried on chromosomes, are the basic physical and functional units of heredity. Genes are specific sequences of bases that encode instructions.
Non-pharmacologic Management There is good evidence to recommend an individualized exercise program for patients with mild to moderate dementia – A simple.
By OPAL & Memory Team Improving the Individual Experience – Getting the System Right EARLY DIAGNOSIS INTEGRATED CARE PATHWAY RBCH Model.
The Worldwide Epidemic of Senile Dementias- Challenges of Pre-Clinical Treatment Evolving Diagnostic Approaches Dimitrios Kapogiannis AAAS 2015 Annual.
Michael Birrer Ian McNeish New Developments in Biology and Targets of Epithelial Ovarian Cancer.
Biomedical Research. What is Biomedical Research Biomedical research is the area of science devoted to the study of the processes of life; prevention.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
April 2005 How Patients Can Benefit From Molecular Imaging Paula M. Jacobs, Ph.D Vice President Advanced Magnetics, Inc.
Knowledge Discovery from Biological and Clinical Data: BASIC BACKGROUND.
Melanie Dunn 9/20/2011.  Rheumatoid arthritis (RA) is a chronic disease that leads to inflammation of the joints and surrounding tissues that can also.
Ch5 Sec2 Human Genetic Disorders. Key Concepts What are two major causes of genetic disorders in humans? How do geneticists trace the inheritance of traits?
Lorenzo’s Oil Obectives: To demonstrate understanding of…..
The Dementia HIT: Who we are and what we do Dr Liz Coulthard.
Stratifying RTT Patients for Clinical Trials A Mutation Based Approach
Gene editing in embryos and germ line
 a type of dementia that causes problems with memory, thinking and behavior. Symptoms usually develop slowly and get worse over time, becoming severe.
Under the supervision of miklós jászberényi
The clinical research of early diagnosis and ultimately the treatment of Alzheimer’s disease 許一仁 董冠廷 詹鎮遠 陳柏廷.
Pathogenesis and pathology of parkinsonism
Update and Thank you to participants Bradley Hyman MD PhD Director, Mass ADRC ViceChair, Neurology, Massachusetts General Hospital.
7.2.9 Students know plant and animal cells contain many thousands of different genes and typically have two copies of every gene. The two copies (or alleles)
(1) Genotype-Tissue Expression (GTEx) Largest systematic study of genetic regulation in multiple tissues to date 53 tissues, 500+ donors, 9K samples, 180M.
Partners in Progress: Deciding to Participate in Parkinson’s Clinical Research.
Professor Orla Hardiman HRB Clinician Scientist Innovation Its role in Delivering Better Health Outcomes.
European Patients’ Academy on Therapeutic Innovation Challenges in Personalised Medicine.
What do we need to know to become stem cell literate?
Modelling Madness Susan Totterdell.
National Healthcare Science Week 2017
NISCHR Academic Health Science Collaboration Launch
Hadley KEY SLIDES 9-5 7:45-8:15 PM
Alzheimer’s Disease Group 廖元祺 楊熙恆
Down syndrome (DS) critical region
Indiana University-Purdue University Indianapolis, Department of Communication Studies Race and Research: Health Communication Strategies to Increase.
Risk of Treatment Failure: Patient Support approaches and strategies
Modifying Disease Course in Alzheimer's Disease
Figure 4 Cerebrospinal fluid levels of neurofilament light chain
Hunter Syndrome: Why We Need to Diagnose and Treat Early
Early Dementia Distinguishing AD From MCI
New Targets, New Modalities, New Challenges – The Inconvenient Path of Human Genetics in Drug Discovery Enabling Precision Medicine: The Role of Genetics.
Figure 1 The genomic nephrology workflow: genetic diagnosis and clinical application Figure 1 |The genomic nephrology workflow: genetic diagnosis and clinical.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Genetic sequence analysis of inherited bleeding diseases
Figure 1 Metabolic profiling as a tool for studying rheumatic diseases
KEY CONCEPT Genetics provides a basis for new medical treatments.
Updates in the Management of Parkinson's Disease Psychosis
Phenogenetic networks of genes linked to Alzheimer's and Parkinson's disease reveal concordant phenotypes Phenogenetic networks of genes linked to Alzheimer's.
KEY CONCEPT Genetics provides a basis for new medical treatments.
The Genetic Basis for Cancer Treatment Decisions
Clinical Genomics in Inflammatory Bowel Disease
Types of biomarkers/biosignatures to be used for cardiovascular disease. Types of biomarkers/biosignatures to be used for cardiovascular disease. There.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Nat. Rev. Neurol. doi: /nrneurol
KEY CONCEPT Genetics provides a basis for new medical treatments.
Expanding glucocerebrosidase involvement in neurodegeneration: D419H mutation causing Dementia with Lewy Bodies G. Palermo, A. Lo Gerfo, V. Nicoletti,
Stratified Medicine: Will it be the Future of Medicine?
Clinical response to anti-ERBB3 mAb therapy in a patient with an advanced NRG1-rearranged non–small cell lung cancer. Clinical response to anti-ERBB3 mAb.
KEY CONCEPT Genetics provides a basis for new medical treatments.
Presentation transcript:

What we are learning about Alzheimer’s disease genetics Bryan J. Traynor

Guerreiro et al, Cell 2013

How geneticists think about disease Guerreiro et al, Cell 2013

Rest of the talk Why is AD genetics important?

Why find genes? Clinical – Diagnosis of patients – Genetic counseling

Genes are the starting point Clinical – Diagnosis of patients – Genetic counseling Scientific – Cell-based and animal based models – Understand the pathogenesis of disease – Provide therapeutic targets

10 years is a long, long time

Riboflavin pathway in Brown-Vialetto-Van Laere Syndrome

Identify the locus Find the gene Identify a target Treatment Understand the pathobiology How else might genetics help?

Identify the locus Find the gene Identify a target Treatment Understand the pathobiology How else might genetics help?

Dementia is not one disease Important for clinical trials – What if a DMD only works on one type? – Select patients based on genetic makeup – Stratify the results based on genotype

How else might genetics help? What if genetics also predicts rate of progression?

How else might genetics help? Disease prediction

Parkinson’s disease 13,708 cases and 95,282 controls Nalls et al, Nature Genetics 2014

Genetics plays a key role in all parts of the circle

What are the challenges Resources are limited From a genetic perspective, disease is complex Recognize that strength lies in integrated studies, but we still need to maintain own identities Many approaches, all valid, all expensive!!!